Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

SRPIF
Sort by: Date|Relevance

FDA Grants Ampio Pharma Approval to Begin Phase 1 Trial in COVID-19 Patients

Ampio Pharmaceuticals' shares traded higher after the company reported that the FDA cleared the firm to proceed with human trials of its Investigative New Drug application for intravenous AmpionTM for treatment in COVID-19 affected patients on supplemental oxygen. ...
Streetwise Reports | June 22, 2020 |

Permex Petroleum: A uniquely positioned junior oil & gas company

The world of oil and gas has been fascinating to watch recently as issues with the global supply chain and ongoing war with Russia and Ukraine have seen prices hit decades-long highs, leading the U.S. government to tap into its strategic reserves and URGE domestic produce...
Daniella Atkinson | October 24, 2022 |

BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

In the past, people have accepted that it usually takes about ten years to get a vaccine on the market. Careful testing with proof of success is required for a preparation to receive approvals. Since COVID-19, the pressure to develop has increased dramatically and also the pot...
Mario Hose | September 1, 2020 |

Buzz on the Bullboards: When will the bear awaken?

2023 has started off with a bang for investors, as many sectors continue to adjust to rising inflation. It has been an up-and-down week for Canadian markets so far, but there seems to be an upbeat sentiment from markets across the globe. Many expect the Federal Reserv...
Jonathon Brown | January 12, 2023 |

The Fed Meets the S&P 500 Bull

Yesterday's Fed statement drove stock lower, but did the overnight slide tick all the boxes so far – that's the question to ask. And why exactly did the market get so disappointed with the FOMC moves? I'll answer these questions in today's analysis, and lay out the prospects f...
Monica Kingsley | June 11, 2020 |

Warning – That’s Not a Buying Opportunity in Gold

Gold rallied by $17.20 yesterday (1.08%), while silver soared by $0.42 (2.35%), which means that silver more than doubled gold’s rally. Silver is outperforming gold, which was both profitable, and informative. Gold miners moved higher even more (4.60% in case o...
Przemyslaw Radomski, CFA | February 19, 2020 |

Why a Period of Consolidation Is Good for Gold

Technical analyst Clive Maund discusses gold's recent price decline and how that could be setting it up for a sustainable breakout. The rather sharp drop in gold late last week, especially on Friday, came as something as a shock to many investors in the sector, yet as w...
Streetwise Reports | March 5, 2019 |

Large US Market Now Open to Livestock Feed Antibiotic Replacement

Proprietary OxC-beta livestock feed supplement can supplant the need for maintenance antibiotics. Antibiotic resistance is a major health threat worldwide and many countries have banned or are banning the use of antibiotics as growth promoters in livestock. The European...
Streetwise Reports | March 12, 2019 |

Outlook for Silver 'Positive'

Technical analyst Clive Maund looks at the silver charts and discusses the metal's upside potential. There were several developments last week that taken together suggest that the short-term bearish scenario set out in the Gold and Silver Interim update about a week a...
Streetwise Reports | April 9, 2019 |

Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target

An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker. In an April 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed the reasons why Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ) is "high on the...
Streetwise Reports | April 18, 2019 |
1 2 3 4 5 6 7 8